High Throughput News and Research

RSS

Ortho introduces second COVID-19 antibody test with 100% specificity

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today introduced and announced the U.S. Food and Drug Administration granted Emergency Use Authorization to its second COVID-19 antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test. This test is one of only a handful of antibody tests to be granted Emergency Use Authorization.

From Ortho-Clinical Diagnostics, Inc. 29 Apr 2020

Research on SARS-CoV-2 spike protein may lead to new vaccines and treatments

The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.

28 Apr 2020

Mapping complex peripheral immune response to severe COVID-19

In a recent article publicly available at medRxiv, researchers from Stanford have presented a single-cell atlas of the peripheral immune response to coronavirus disease (COVID-19), highlighting pertinent immunological features associated with the severe forms of the disease.

26 Apr 2020

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates.

24 Apr 2020

Sygnature Discovery loans key equipment to support UK Government’s COVID-19 testing strategy

Sygnature Group is supporting the Government’s COVID-19 testing strategy with the loan of a key piece of equipment. The machine, a Tecan Freedom EVO 100, will be used to help automate and accelerate the analysis of samples at the first of the UK Government’s new Lighthouse Labs in Milton Keynes.

24 Apr 2020

UAB to join international effort to test drugs for COVID-19

The University of Alabama at Birmingham will join an international effort coordinated by Scripps Research to test drugs for COVID-19.

24 Apr 2020

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Ablexis, LLC, ADS, and Berkeley Lights, Inc. today announced the generation and recovery of sequences against the S1 spike protein of the SARS-CoV-2 virus.

From Bruker Cellular Analysis 23 Apr 2020

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta Group plc is pleased to announce that it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen.

From Avacta Life Sciences Ltd. 22 Apr 2020

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating antibody discovery using picodroplet technology for single cell analysis to condense discovery times down to 1-2 days.

From Fluidic Sciences and Sphere Bio 22 Apr 2020

P-BEST: Fast efficient COVID-19 virus testing before symptoms appear

A highly promising new study published on the preprint server medRxiv in April 2020 reports an efficient new method to conduct high-throughput testing of blood samples for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is causing the rapidly spreading pandemic of COVID-19 disease throughout the world. The method could revolutionize the diagnosis of new cases before they become symptomatic.

22 Apr 2020

New high-throughput approach yields libraries of probes for immunological assays

An immunological test known as a "tetramer assay" can detect T cells in a blood sample that recognize a specific antigen.

20 Apr 2020

UniFrac microbiome tool optimized for computer GPUs

Researchers at the San Diego Supercomputer Center (SDSC) at the University of California San Diego have been applying their high-performance computing expertise by porting the popular UniFrac microbiome tool to graphic processing units in a bid to increase the acceleration and accuracy of scientific discovery, including urgently needed COVID-19 research.

18 Apr 2020

A sensor chip smaller than a ladybug records multiple lung and heart signals

During a stroll, a woman's breathing becomes a slight bit shallower, and a monitor in her clothing alerts her to get a telemedicine check-up.

16 Apr 2020

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

The U.S. Food and Drug Administration today announced it granted Emergency Use Authorization to Ortho Clinical Diagnostics' total antibody assay for COVID-19—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators.

From Ortho-Clinical Diagnostics, Inc. 16 Apr 2020

Toxic cell atlas can guide discovery of new drugs for neurodegeneration

A common thread in many inflammatory and neurodegenerative diseases, including multiple sclerosis (MS), is damage caused by oxidative stress. Oxidative stress occurs when cells produce toxic substances known as reactive oxygen species, which are damaging nerve cells and other cells in the body.

13 Apr 2020

Chinese scientists report high-resolution crystal structure of COVID-19 main protease

A team of Chinese scientists has reported the high-resolution crystal structure of the main protease (Mpro) of the COVID-19 virus and has identified drugs that may hold promise in combating the virus.

13 Apr 2020

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.

13 Apr 2020

Promising COVID-19 drug treatments identified with new screening strategies

As scientists across the world race to find a pharmacological cure for coronavirus disease (COVID-19), an international research group has analyzed more than 10 thousand different compounds and identified six potential candidates, publishing their results in the leading scientific journal Nature.

12 Apr 2020

UMSOM launches new initiative to expand COVID-19 testing

University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today the launch of a large-scale COVID-19 Testing Initiative that will significantly expand testing capability over the coming weeks, enabled by new funding of $2.5 million from the State of Maryland.

12 Apr 2020

Researchers identify COVID-19 drug lead treatments

An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.

9 Apr 2020

High Throughput News and Research

Ortho introduces second COVID-19 antibody test with 100% specificity

Research on SARS-CoV-2 spike protein may lead to new vaccines and treatments

Mapping complex peripheral immune response to severe COVID-19

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Sygnature Discovery loans key equipment to support UK Government’s COVID-19 testing strategy

UAB to join international effort to test drugs for COVID-19

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

P-BEST: Fast efficient COVID-19 virus testing before symptoms appear

New high-throughput approach yields libraries of probes for immunological assays

UniFrac microbiome tool optimized for computer GPUs

A sensor chip smaller than a ladybug records multiple lung and heart signals

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

Toxic cell atlas can guide discovery of new drugs for neurodegeneration

Chinese scientists report high-resolution crystal structure of COVID-19 main protease

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Promising COVID-19 drug treatments identified with new screening strategies

UMSOM launches new initiative to expand COVID-19 testing

Researchers identify COVID-19 drug lead treatments

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News